milademetan: Clinical Trials

10 trials of milademetan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 terminated, 3 completed, 1 withdrawn. 6 Phase 1, 3 Phase 2, 1 Early Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 16Terminated 3, Completed 2, Withdrawn 1
Phase 23Terminated 2, Withdrawn 1
Early Phase 11Completed 1
Phase 31Terminated 1

Follow milademetan: new trials by email Literature Review of milademetan trials Research Report on milademetan

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Milademetan and Fulvestrant in GATA3-mutant, ER+HER- Advanced or Metastatic Breast Cancer
Milademetan, Patient Reported Outcomes (PROs) and Health-Related Quality of Life (HRQOL) - Advanced or Metastatic Breast Cancer
Phase 2TerminatedInstitut Curie12023-10-122023-12-21
Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss
Milademetan, Atezolizumab - Advanced Solid Tumor, CDKN2A
Phase 1 / Phase 2WithdrawnRain Oncology Inc2023-05-192023-10-19
A Study of Milademetan Administration on Cardiac Repolarization in Healthy Subjects
Placebo, Moxifloxacin (positive control), Milademetan - Cardiac Repolarization
Phase 1TerminatedRain Oncology Inc62023-04-172023-08-08
Milademetan in Advanced/Metastatic Solid Tumors
RAIN-32 - Solid Tumors, Head and Neck Carcinoma
Phase 2TerminatedRain Oncology Inc402021-11-012024-10-17
Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma
RAIN-32, Trabectedin - Dedifferentiated Liposarcoma
Phase 3TerminatedRain Oncology Inc1752021-07-142025-01-14
Milademetan Plus Quizartinib Combination Study in FLT3-ITD Mutant Acute Myeloid Leukemia (AML)
Quizartinib, Milademetan - Acute Myeloid Leukemia
Phase 1TerminatedDaiichi Sankyo102018-12-122022-05-20
Study of Milademetan in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Milademetan - Acute Myeloid Leukemia
Phase 1CompletedDaiichi Sankyo Co., Ltd.142018-08-232023-11-07
Pharmacokinetics (PK) Drug Interaction Study of Milademetan and Itraconazole or Posaconazole in Healthy Participants
Milademetan, Itraconazole, Posaconazole - Pharmacokinetics
Early Phase 1CompletedDaiichi Sankyo362018-07-132019-02-12
Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Milademetan, AZA - Acute Myelogenous Leukemia, Myelodysplastic Syndrome
Phase 1TerminatedDaiichi Sankyo742014-11-252021-10-11
A Multiple Ascending Dose Study of Milademetan in Subjects With Advanced Solid Tumors or Lymphomas
Milademetan - Advanced Solid Tumor, Lymphoma
Phase 1CompletedDaiichi Sankyo1072013-07-112025-03-27

Conditions studied

Leukemia, Myeloid, Acute (3)  ·  Melanoma (2)  ·  Recurrence (2)  ·  Sarcoma (2)  ·  Stomach Neoplasms (2)  ·  Adenocarcinoma of Lung (1)  ·  Adrenocortical Carcinoma (1)  ·  Biliary Tract Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)  ·  Cholangiocarcinoma (1)  ·  Liposarcoma (1)  ·  Lymphoma (1)  ·  Mesothelioma (1)

Sponsors

Daiichi Sankyo (4)  ·  Rain Oncology Inc (4)  ·  Daiichi Sankyo Co., Ltd. (1)  ·  Institut Curie (1)

Countries

United States (6)  ·  France (2)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Canada (1)  ·  Georgia (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Ireland (1)  ·  Italy (1)  ·  Japan (1)  ·  Poland (1)  ·  South Korea (1)  ·  Spain (1)

Results publications

PMID 36669146, PMID 39030997, PMID 40327322